ubmslateEN-logo-ubm

EN Mobile Logo

Search form

Topics:

Home

Type 2 Diabetes and Insulin: Physician Reluctance

Do you hesitate to initiate insulin therapy in type 2 diabetes patients? To understand barriers, researchers conducted a cross-sectional survey.

 

© Sherry Yates Young/Shutterstock.com

Recent Content

How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?

Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.

Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?

How would you treat glucose excursions in a patient treated with prednisone?

When choosing a healthcare provider, many consumers value online reviews of physicians. How can you make the most of this opportunity?

Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.

A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.

By clicking Accept, you agree to become a member of the UBM Medica Community.